Skip to main content Accessibility help
×
Home

DDAVP as a Possible Method to Enhance Positive Benefit of Behaviour Therapy

  • David Greenberg (a1) and Robert H. Belmaker (a2)

Copyright

Corresponding author

Correspondence

References

Hide All
Anderson, L. F., David, R., Bannet, K. & Dancis, J. (1979) Positive avoidance learning in Lesch-Nyhan disease: Effect of DDAVP. Life Science, 24, 905910.
Ang, V. T. Y. & Jenkins, J. S. (1982) Blood CSF barrier to arginine-vasopressin, depression, and desglycinamide arginine-vasopressin in the dog. Journal of Endocrinology, 93, 319325.
Beckwith, B. E., Petros, T., Kanaan-Beckwith, S., Coule, D. I. & Haug, R. J. (1982) DDAVP facilitates concept learning in human males. Peptides, 3, 627630.
Delwaide, P. J., Devoitille, J. M. & Ylieff, M. (1980) Acute effect of drugs upon memory of patients with senile dementia. Acta Psychiatrica Belgica (Bruxelles), 80, 748754.
De Wied, D. (1971) Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats. Nature, 232, 5860.
Gold, P. W., Ballenger, J. C., Weingartner, H., Goodwin, F. K. & Post, R. M. (1979) Effects of l-desamino-8-D-arginine vasopressin on behaviour and cognition in primary affective disorders. Lancet, i, 992994.
Jenkins, J. S., Mather, H. M. & Coughlan, A. K. (1982) Effect of desmopressin on normal and impaired memory. Journal of Neurology, Neurosurgery and Psychiatry, 45, 830831.
Jolles, J. (1983) Vasopressin-like peptides and the treatment of memory disorders in man. Progress in Brain Research, 60, 169182.
Laczi, F., Valkusz, Z. S., Laszlo, F. A., Wagner, A., Jardanhazy, T., Szasz, A., Szilard, J. & Teledgy, G. (1982) Effects of lysine-Vasopressine and 1-desamino-8-arginine-vasopressine on the memory in healthy individuals and diabetes insipidus patients. Psychoneuroendocrinology, 7, 185193.
Marks, I. M., Stern, R. S., Mawson, D., Cobb, J. & Mcdonald, R. (1980) Clomipramine and exposure for obsessive-compulsive rituals (1980). The British Journal of Psychiatry, 136, 125.
Mathews, A. M., Gelder, M. G. & Johnston, D. W. (1981) Agoraphobia: Nature and Treatment. Tavistock, London.
Medvedev, V. I., Bakharev, V. D., Grechko, A. T. & Nezovibat'Ko, V. N. (1981) Effect of vasopressin and adrenocortico-trophic hormone fragment of ACTH on human memory. Human Physiology, 6, 307310.
Rachman, S. J. & Hodgson, R. (1980) Obsessions & Compulsions. Prentice-Hall, Englewood Cliffs, New Jersey.
Saghal, A. (1983) Vasopressin retards the acquisition of positively-reinforced lever-pressing in homozygous Brattleboro rats. Regulatory Peptides, 5, 317326.
Steketee, G., Foa, E. B. & Grayson, J. B. (1982) Recent advances in the behavioral treatment of obsessive-compulsives. Archives of General Psychiatry, 39, 13651371.
Timsit-Berthier, M., Mantanus, H., Jacques, M. C. & Legros, J. J. (1980) Utilite de la lysine-vasopressine dans le traitement de l'amnesie post-traumatique. Acta Psychiatrica Belgica (Bruxelles), 80, 728747.
Weingartner, H. P., Gold, J. C., Ballenger, S. A., Smallberg, R., Summers, D. R., Rubinov, D. R., Post, R. M. & Goodwin, F. K. (1981) Effects of vasopressin on human memory function. Science, 211, 601603.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

DDAVP as a Possible Method to Enhance Positive Benefit of Behaviour Therapy

  • David Greenberg (a1) and Robert H. Belmaker (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *